Theme: Novel Insights On Pediatrics and Adolescent Diabetes

Adolescent Diabetes 2019

Renowned Speakers

Adolescent Diabetes 2019

Conference Series invites worldwide global audience and presenters to participate at the 31st International Conference on Pediatric and Adolescent Diabetes which is to be held in  Tokyo, Japan during August 12-13, 2019. Special interest and theme of the conference is “Novel  Insights On Pediatrics and Adolescent Diabetes”.

Adolescent Diabetes 2019 aims to provide an opportunity to share knowledge, expertise along with unparalleled networking opportunities between a large number of medical and industrial professionals in this sphere. The meeting gathers renowned scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine under a single roof where networking and global partnering happens for the acceleration of future research. This conference is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society. Adolescent Diabetes  2019 is where the future of management and novel therapeutics for the disease intersects.

Why to attend?

Adolescent Diabetes  2019 highlights the theme “Novel  Insights On Pediatrics and Adolescent Diabetes” Which emphasis on the latest advancements in prevention and treatment cure of various metabolic diseases which may be due to diabetic and endocrine complications and provides robust discussions on methods and strategies related to diagnosis, prevention and management of metabolic disorders as well as explore new ideas and concepts for treatment of Endocrine Complications.. 

Target Audience:

  • Endocrinologists
  • Diabetologists
  • Researchers
  • Practitioners/Doctors
  • Students
  • Nurse educator
  • Podiatrist
  • Dietitian
  • Eye Doctors
  • Nephrologists
  • Physical trainer or Exercise physiologist                                                                                                                         

Track 1: Diabetes Type and Symptoms

Diabetes Mellitus is a cluster of metabolic diseases resulting in prolonged high blood sugar. Diabetes causes either due to inadequate insulin production, mentioned as type one diabetes or because of the resistance to insulin by body’s cells, mentioned as type two diabetes or sometimes both. Symptoms of diabetes include polyuria along with an increase in hunger and thirst.

  • Type 1 Diabetes
  • Type 2 Diabetes
  • Borderline Diabetes
  • Polyuria
  • Pre-Diabetes

Track 2: Diabetic Nutrition & Physical Fitness

Physical fitness and diet are imperative parts of a sound way of the life when you have diabetes. Alongside different advantages, following a healthy balanced diet and being dynamic can enable you to keep your blood glucose level in objective range. To deal with the blood glucose, you must adjust with what you drink and eat along with medications and physical movement. The quality and quantity of food that you eat are extremely vital in keeping your blood glucose level in the range that your healthcare professional suggests.

  • Exercise for diabetics
  • Lifestyle Intervention and Diabetes Prevention
  • Protein intake and Diabetes
  • Food combinations and diabetes
  • Diet for Diabetics
  • Nutrition for Diabetics

Track 3: Diabetic Education and Healthcare Professionals

Diabetes education is an integral component of the diabetes care and management, because diabetes requires day-to-day knowledge of  exercise, nutrition, monitoring, and medication. An healthy diet is the central to manage of diabetes. The aim of patient education is for people with diabetes to improve their skills, knowledge and confidence enabling them to take increasing control of their own condition and integrate effective self-management into their daily lives. High-quality structured education can have an effect on health outcomes and can also significantly improve quality of life. The potential benefits of an effective patient education programme for people with diabetes should include health beliefs, improving knowledge, lifestyle changes and improving patient outcomes - eg, haemoglobin A1c (HbA1c), lipid levels, weight, smoking and psychosocial changes, improving levels of physical activity, reducing the need for - and potentially better targeting of - medication and the other items such as blood testing strips.

  • Weight management
  • Psychosocial adjustment
  • Medication adherence in diabetes
  • Nutritional management
  • Diabetes disease process
  • Glucose monitoring
  • Education for insulin users and non-insulin users 

Track 4: Endocrinology

Endocrinology diseases may relate too high or low secretion of a hormone, too much or too little action of a hormone, or problems with receiving the hormone. Common endocrine disorders include Addison’s disease, diabetes mellitus, Cushing’s syndrome, Graves’ disease, Hashimoto’s thyroiditis, acromegaly, hyperthyroidism and hypothyroidism. These disorders often have widespread symptoms, affect multiple parts of the body, and can range in severity from mild to severe. Treatments relays on adjusting the hormone balance using synthetic hormones. Untreated endocrine problems can have widespread complications throughout the body.

  • Reproductive endocrinology and infertility
  • Niemann- Pick syndrome
  • Polycystic ovary syndrome
  • Grave’s disease
  • Osteoporosis
  • Cushing’s disease
  • Congenital adrenal hyperplasia
  • Paget’s disease and rickets

Track 5: Medical Devices and Technologies used in Diabetes Treatment

The most common devices utilized in the diabetes include blood-glucose meters, insulin pens and insulin pumps. An artificial pancreas is the machine which would monitor blood sugar levels using an array of sensors, and unleash insulin from the reservoir into the blood, using infusion pump, whenever it's needed. Current gene therapy study highlights the transfer of insulin gene into different cells like the intestines, liver, stomach.

  • Drug Therapy and Insulin Pumps
  • Telemedicine and Computational Application
  • Gene Therapy and Cell-Replacement Therapy
  • Monoclonal Antibodies
  • Bioartificial Pancreas
  • Bariatric Surgery
  • Bioinformatics in Diabetes Mellitus

Track 6: Stem Cell Therapy and Nanotechnology in Diabetes

A successful stem cell or bone marrow transplant could facilitate slow or halt the progression of certain metabolic syndromes together with type one diabetes, however, early diagnosis is vital to prevent irreversible disease progression. Pancreatic islet allotransplantation is the procedure in which islets from donor pancreas are transferred to other person to treat type one diabetes and have been a promising cellular-based therapy. The recent innovations in nanomedicine include smart medication that solely activates when needed, nanoformulations for efficient drug delivery, engineered microbes that manufacture human hormones, and even nanorobots, which would move autonomously around the body acting as a boost, biological systems for our immune system and red blood cells.

  • Mesenchymal Stem Cell Therapy
  • Islet Cell Transplantation
  • Embryonic Stem Cells

Track 7: Genetic Basis of Diabetes

Along with the nutrition and exercise, genetics plays a serious role for an individual to develop type two diabetes. The heritability of metabolic syndrome and diabetes is comparatively high and several other gene mutations are coupled to the event of type two diabetes. About 70% of this kind of diabetes patient inherited the disease from the previous generation.

  • Diagnosis and Management Resources
  • Reducing the Risk of Passing Diabetes
  • Lifestyle Choices that Affects the Development of Type 2 Diabetes
  • Genetic Testing for the Type 2 Diabetes and Prevention Tips
  • The Role of the Genetics in Type 2 Diabetes

Track 8: General Pediatrics

Pediatrics is the branch of treatment that includes the medicinal care of adolescents, new-born children and teenagers. The main theme of the investigation of paediatrics is to decrease new-born and neonatal rate of deaths, control the spread of illnesses and furthermore to advance wide-range of lifestyles for a long infections free life and helps to lessening the issues of kids and adolescents. A pediatrician is a specialist who will deal with the mental, physical and all health aspects of their paediatric patients, in all phase of development.

Track 9: Pediatric Infectious diseases

Pediatric infectious diseases are the illnesses which will influence the child have a routine or persistence disease caused by infectious agents such as Fungus, Bacteria and a parasite viral disease etc. Paediatric infectious diseases professionals treat an extensive variety of immunologic diseases and infections that are complex or atypical. Some of the Paediatric infectious diseases incorporate skin diseases, joint diseases, bone infections, blood contaminations.

Track 10: Pediatric Endocrinology

Pediatric endocrinology is a medicinal subspecialty managing disorders of the endocrine organs, such as variations in sexual development and  physical development in diabetes, teens and some more. Pediatric endocrinologists will treat the children depending upon their age factor and also they will care for the patients from earliest stages to young adulthood and late adolescence. Pediatric endocrinologist are medicinal specialists will treat the youngsters having issues with adolescence, diabetes, development or different issue identified with the hormones and the organs that create them.

Track 11: Pediatric and Adolescent Diabetes

Diabetes normally saw in childrens is Type 1 diabetes and is caused by the failure of the pancreas to deliver insulin. Type1 diabetes affects around 1 out of 400 adolescents, children and young adults under 20 years of age. Moreover, it is because of the autoimmune destruction of the beta cells in the pancreas. The diagnosis is made when a child has typical symptoms of diabetes with ketones in the urine and unusually high glucose levels in blood. Type 1 diabetes is a long lasting disease that can't be cured completely. Mostly, the administration of insulin is an extremely powerful treatment for type 1 diabetes.

Track 12: Pediatric Allergy

Allergies erupt in children’s more habitually than adults. Allergens are the only substances that cause allergic reaction in humans. This is mainly due to the reason that children immune systems hasn't developed completely, and they have to be protected against various allergens. Allergist will treat and analyse the conditions or diseases caused by allergic agents. Children experiencing allergic reactions are treated by Allergist.

Track 13: Hypercholesterolemia and Hyperlipidaemia

Hyperlipidemia has no symptoms, so the only way to detect it is to have your doctor perform a blood test called a lipid profile or a lipid panel. Lifestyle changes are the important aspects for managing hyperlipidemia. Hyperlipidemia is the presence of high levels of fats in the blood. The two major types of lipids found in the blood are cholesterol and triglycerides. Hypercholesterolemia, also called as high cholesterol, is a medical term for the high levels of cholesterol in blood.  Elevated levels of cholesterol in the blood may be an outcome of obesity, unhealthy diet, inherited or the presence of other diseases such as type 2 diabetes. These changes alone may be enough to reduce the risk of complications like heart disease and stroke. It causes LDL (bad) cholesterol level to be very high. The condition begins at birth and can cause heart attacks at an early age.

  • Familial hypercholesterolemia
  • Alzheimer’s disease
  • Hemorrhagic stroke
  • Cholestatic liver disease
  • Apoprotein disorders
  • Peripheral arterial disease
  • Diagnosis, treatments and medications

Track 14: Diabetes and Obesity

Obesity is a medical condition which results from the accumulation of excess fat within the body. Obesity is thought to trigger the changes to the body's metabolism. It adds pressure on body's ability to use insulin, to properly control blood sugar levels, and therefore they are more likely to develop diabetes. In addition abdominal fat influences fat cells to release ‘pro-inflammatory’ chemicals, which can reduce insulin sensitivity by disrupting the function of insulin responsive cells and their ability to respond to insulin. Obesity also causes pre-diabetes, a metabolic condition that almost always develops into type 2 diabetes.

Obesity has many causes such as gender, genes, age, psychological makeup, environmental factors and socioeconomic makeup. Certain medical conditions and medications can promote or cause obesity, although these are much less common causes of obesity than inactivity and overeating. Some examples of these are depression, certain medications (examples are antidepressants, control pills, steroids), Polycystic ovarian syndrome, Prader-Willi syndrome. The main goal of obesity treatment is to stay at a healthy weight. All weight-loss programs focus on physical activity and eating habits.

  • Control of obesity
  • Weight management
  • High blood pressure and obesity
  • Type 2 diabetes and obesity
  • Advanced treatment for obesity
  • Glucose intolerance
  • Gallbladder disease
  • Endocrinal and hormonal obesity
  • Over weight and cancer risk

Track 15: Metabolic Syndrome

Metabolic syndrome is a combination of risk factors which includes high blood pressure, abnormal cholesterol levels, hyperglycemia and excess body fat around the waist that occur together, doubling your risk of heart stroke, diabetes and hyperglycemia.  This condition is also known by other names including Syndrome X, dysmetabolic syndrome, insulin resistance syndrome. Insulin resistance, metabolic syndrome and prediabetes have overlapping aspects and are closely linked to each other. Most of the disorders associated with metabolic syndrome have no symptoms, although it is closely linked to insulin resistance, inactivity and overweight or obesity. Metabolic syndrome can be prevented or reversed by adopting few number of lifestyle changes, including regular exercise, healthy diet, losing weight, stopping smoking, cutting down on alcohol. Liver enzymes is an indicator of non-alcoholic fatty liver disease, may comprise an additional component of the metabolic syndrome and may serve as a surrogate marker for type 2 diabetes.

  • Diagnosis, treatments and medications
  • Advances in BMI testing
  • Metabolic disorders and stem cell transplantation
  • Nursing care and paediatrics
  • Pathophysiology of metabolic syndrome
  • Risk factors associated with metabolic syndrome

Track 16: Cholesterol, High Blood Pressure and Diabetes

Cholesterol is an organic substance that body uses to produce vitamin D, build healthy cells and make certain hormones. High cholesterol and diabetes are linked with each other. Diabetes can disturb the balance between LDL and HDL cholesterol levels. LDL particles of the people with diabetes tend to stick to arteries and can damage blood vessel walls easily. Glucose coated LDL remains in the bloodstream longer and leads to the formation of plaque. Low levels of HDL are seen in the people with diabetes. Both of these increase the risk of artery disease And heart. There is a link between the high blood pressure (hypertension) and high cholesterol. When the arteries become narrowed and hardened with cholesterol plaque, the heart has to force much harder to pump blood within them. As a result, blood pressure becomes abruptly high.

  • Impaired blood vessels
  • Increase in the amount of body fluids
  • Changes in insulin management
  • Good (HDL) and bad (LDL) cholesterols
  • Dietary sources of cholesterol
  • Lifestyle changes to lower cholesterol
  • Circulation problems


Track 17: Cholesterol Metabolism and Diabetes

Cholesterol metabolism is altered in the diabetes. Absorption is decreased in diabetes and cholesterol biosynthesis is increased. The increased cholesterol synthesis can be lowered by insulin. Low cholesterol absorption efficiency has reported earlier in the limited number of diabetic subjects with mild hyperlipidemia and moderately overweight. In type-2 diabetes in obesity and also in conditions such as cortisol excess (Cushing’s Syndrome), raised insulin levels are found frequently. Lack of insulin can lower the level of "good" cholesterol (high density lipoprotein). When insulin is given and then well controlled, HDL numbers will typically go back to normal. Cholesterol problems in people who have type-1 diabetes are related to the lack of insulin. Gestation diabetes mellitus is associated with higher cholesterol synthesis in the first trimester, and the elevated serum squalene levels in the second and third trimester of pregnancy, and that cholesterol synthesis and maternal serum squalene correlates with birth weight.

  • Insulin resistance
  • Enterohepatic circulation
  • Sterols and diabetes
  • Cholesterol absorption
  • Cholesterol synthesis
  • The succinate hypothesis

Track 18: Gestational Diabetes

Gestational diabetes is a type of diabetes in which woman develop high blood sugar levels during pregnancy. Pregnancy hormones compete with insulin for the insulin receptor. Pregnancy hormones and increased body fat deposits during pregnancy mediate insulin resistance during pregnancy. Insulin resistance prevents glucose from entering into the cells properly. In addition, glucose remains in the bloodstream, where glucose levels rise. It can be managed by healthy diet and exercise. Insulin injections are the common medical treatment for gestational diabetes. If gestational diabetes is not detected and controlled, it may increase the risk of baby birth complications, such as shoulder dystocia (when the baby's shoulder gets stuck during the birth). Babies of mothers with gestational diabetes may experience hypoglycaemiarespiratory distress syndrome and can also be large for their gestational age. Women with gestational diabetes are at risk of developing diabetes mellitus later in life.

  • Prediabetes
  • Risk factors for gestational hypertension
  • Placental hormones
  • Monitoring fetal growth and well-being
  • Etiology and pathogenesis
  • Prognosis of gestational diabetes

Track 19: Diabetes Complications

Several complications are seen due to uncontrollable diabetes. Long-term complications of diabetes develop gradually. They are divided into  macrovascular (due to damage to larger blood vessels) and microvascular (due to damage to small blood vessels). Microvascular complications include kidney failuredamage to eyes and impotence. Macrovascular complications include cardiovascular diseases such as heart strokes, insufficiency in blood flow to legs, heart attacks. The other factors that quicken the complications of diabetes include smoking, obesityhigh cholesterol levels, lack of exercise and high blood pressure. By controlling the regular diabetes check-ups and blood sugar level , risk of complications can be lowered. Early recognition and prevention of the diabetic complications are mandatory for the psychological outcome of these patients and improvement of the quality of life.

  • Diabetic nephropathy
  • Diabetic foot disorder
  • Stiff person syndrome
  • Diabetic ketoacidosis
  • Diabetic coma
  • Diabetic retinopathy
  • Diabetic neuropathy
  • Celiac disease

“31st International Conference on Pediatric and Adolescent Diabetes” is going to be held during August 12-13, 2019 Tokyo, Japan. The Conference will be organized around the theme “Novel Insights on Pediatrics and Adolescent Diabetes” highlighting the latest and exciting innovations in Diabetes Disease& Treatment. ADOLESCENT DIABETES 2019 Conference invites all Academic Scientists, Leading Endocrinologists, Surgeons, Oncologists, Radiation Therapists, General Physicians, Dieticians, Primary Health care specialists, Internists, Pharmaceutical Industrial Delegates, talented young scientists, and student communities across the globe to attend European Diabetes conference under a single roof where networking and global partnering happens for the acceleration of future research.

Today’s Market Study of Diabetes in Asia Pacific | Europe | Middle East | USA

Middle East: The rate of diabetes in parts of the Arabian Peninsula is over twice the global average rate, and much higher than some other areas of the Middle East and North Africa (MENA). And cases of type-2 diabetes outnumber cases of type-1 diabetes by a ratio of 10:1.

Asia Pacific: The Asia-Pacific Diabetes Care Devices Market has been estimated at USD 2.461 Billion in 2015 and is projected to reach USD 3.518 billion by 2020, at a CAGR of 7.41% during the forecast period from 2015 to 2020.

Europe: The number of people living with diabetes in Europe is expected to increase from 52 million in 2014 to 68.9 million by 2035, according to the International Diabetes Federation (IDF). Across Europe, around 1 in 11 adults is affected and this number is set to rise as the population ages.

USA: Diabetes Mellitus has been growing at an exponential rate and World Health Organization (WHO) estimates that the diabetic population is likely to reach 366 million in 2030. The United States is expected to have an increase of 102 per cent in the diabetic epidemic in 2030 when compared to 2000

For more details please visit-

Conference Highlights:

  • Endocrinology
  • Hypercholesterolemia and Hyperlipidaemia
  • Diabetes and Obesity
  • Metabolic Syndrome
  • Epidemiology of Diabetes
  • Diabetic Education and Healthcare Professionals
  • Cholesterol, High Blood Pressure and Diabetes
  • Lipid Metabolism and Diabetes
  • Cardiovascular Diseases and Metabolic Risk
  • Diabetes Mellitus
  • Gestational Diabetes
  • Diabetes Complications
  • General Pediatrics
  • Pediatric Infectious diseases
  • Pediatric Allergy
  • Pediatric and Adolescent Diabetes
  • Pediatric Endocrinology

Importance & Scope:

Diabetes is also a chronic disorder of glucose metabolism and should be a serious reason behind wellness, heart condition cardiomyopathy cardiovascular disease and end-stage nephritic disease in European populations, the one biggest reason behind preventable visual impairment, the leading reason behindnon-traumatic lower extremity amputation and major reason behind premature mortality. The lay trend and geographical variation of kind 2 polygenic disease counsel that genes and lifestyles act in their influence on hexose metabolism and conjointly the event of polygenic disease. The prevalence of polygenic disease is rising worldwide. In  Asia-pasific, between 35-40% of people will develop polygenic disease over their amount of your time, accounting for up to 10 of all funds spent on care. the need to grasp its aetiology and to develop preventive ways that is, therefore, key to rising the health of the overall public and to reducing the burden on the health care system. Diabetes describes a bunch of metabolic disorders outlined by accumulated aldohexose concentration. People living with inherited disorder have a much better risk of morbidity and mortality than the final population. The planet prevalence of inherited disorder in adults has been increasing over recent decades. In 1964, it had been determinable that thirty million people had polygenic disease. The International polygenic disease Federation (IDF) determinable the planet prevalence to be 151 million in 2000, 194 million in 2003, 246 million in 2006, 285 million in 2009, 366 million in 2011 and 382 million in 2013. Each estimate was supported the foremost recent data out there. The unit Atlas methodologyology was well updated in 2011 to incorporate associate analytic hierarchy method that formalised the ways to position the simplest quality data from out there sources. For the first time, the Israeli Defence Force polygenic disease Atlas methodology in addition includes uncertainty intervals to mirror confidence levels around the prevalence estimates. These uncertainty measurements permit the comparison of the Israeli Defence Force polygenic disease Atlas estimates with totally different sources and over time.

Why Japan?

There were over 7,234,200 cases of diabetes in Japan in 2017. In Japan prevalence of diabetes in adults is 7.7% and total cases of diabetes in adults is 7,234,200. Japan has 7.2 million people diagnosed with diabetes. The average cost is more than ¥400,000 per patient in a year which is mostly covered by national health insurance. About 7.6% of adults between the ages of 20-79 are diabetic and it is estimated that Japan may have more than 3 million undiagnosed cases. Reason for the increase of diabetes in Japan is the increasing population that is over 60, an age when Type 2 diabetes becomes more prevalent.

Insulin pumps:

Insulin pump usage in Scotland currently stands at only 2%.Charities such as Diabetes UK and the JDRF have been campaigning for wider availability of insulin pumps. The Scottish Diabetes Action Plan 2010 commits to make “significant and sustained progress” to increase access to insulin pump therapy over the next three year

Self-testing for Type 2 diabetics:

In March 2010 the NHS National Institute for Health Research published report which concluded that self-monitoring of blood glucose levels for people with type 2 diabetes is unlikely to be cost effectiveness in improving their blood sugar control.

The report makes for disappointing reading among those type 2 diabetics who rely on regular blood testing to manage their diabetes.


Description: Endocrinology2019

Statistics of Diabetes in Japan:

Description: Endocrinology2019


International Associations:

  • The American Association of Endocrine Surgeons
  • Association of Program Directors in Endocrinology, Diabetes and Metabolism
  • Society for Endocrinology
  • Endocrine Society
  • American Association of Clinical Endocrinologists
  • International Society of Endocrinology
  • Pediatric Endocrine Society
  • Brazilian Society of Surgical Endocrinology
  • British Society for Pediatric Endocrinology and Diabetes
  • European Society of Endocrinology


The information developed in this report is intended only for the purpose of understanding the scope of hosting related international meetings at the respective locations. This information does not constitute managerial, legal or accounting advice, nor should it be considered as a corporate policy guide, laboratory manual or an endorsement of any product, as much of the information is speculative in nature. Conference Organizers take no responsibility for any loss or damage that might result from reliance on the reported information or from its use

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date August 12-13, 2019
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1
Poster Opportunity Closed Click Here to View